EZH2 and neoplasm: It has been demonstrated that EZH2 is overexpressed in a variety of malignancies and is associated with a poor prognosis and that downregulating EZH2 expression can inhibit tumor cell proliferation, migration, and invasion [6,7,8,9,10,11].